BSX Q3 2020 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.7B-1.8% YoY

Gross Profit

$1.6B59.2% margin

Operating Income

$262M9.9% margin

Net Income

-$155M-5.8% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+32.8%

Cash Flow

Operating Cash Flow

$643M

Free Cash Flow

$493M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$30.8B

Total Liabilities

$15.3B

Stockholders' Equity

$15.6B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.7B	$2.7B	-1.8%
Gross Profit	$1.6B	$1.7B	-9.1%
Operating Income	$262M	$397M	-34.0%
Net Income	-$155M	$126M	-223.0%

Revenue Segments

Cardiovascular

$1.0B55%

MedSurg

$825M45%

Geographic Segments

UNITED STATES

$1.6B59%

Non-US

$1.1B41%